Salarius Pharmaceuticals Statistics
Total Valuation
SLRX has a market cap or net worth of $1.93 million. The enterprise value is -$1.02 million.
Important Dates
The next estimated earnings date is Friday, March 21, 2025, after market close.
| Earnings Date | Mar 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SLRX has 1.44 million shares outstanding. The number of shares has increased by 103.91% in one year.
| Current Share Class | 1.44M |
| Shares Outstanding | 1.44M |
| Shares Change (YoY) | +103.91% |
| Shares Change (QoQ) | +113.50% |
| Owned by Insiders (%) | 2.52% |
| Owned by Institutions (%) | 1.17% |
| Float | 1.33M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.66 |
| P/TBV Ratio | 0.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.09, with a Debt / Equity ratio of 0.11.
| Current Ratio | 4.09 |
| Quick Ratio | 3.51 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -110.87% and return on invested capital (ROIC) is -66.56%.
| Return on Equity (ROE) | -110.87% |
| Return on Assets (ROA) | -53.17% |
| Return on Invested Capital (ROIC) | -66.56% |
| Return on Capital Employed (ROCE) | -178.36% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.50M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.39% in the last 52 weeks. The beta is 0.84, so SLRX's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | -70.39% |
| 50-Day Moving Average | 1.91 |
| 200-Day Moving Average | 2.14 |
| Relative Strength Index (RSI) | 32.32 |
| Average Volume (20 Days) | 71,134 |
Short Selling Information
The latest short interest is 19,341, so 1.34% of the outstanding shares have been sold short.
| Short Interest | 19,341 |
| Short Previous Month | 311,722 |
| Short % of Shares Out | 1.34% |
| Short % of Float | 1.46% |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.22M |
| Pretax Income | -6.46M |
| Net Income | -4.99M |
| EBITDA | -5.21M |
| EBIT | -5.22M |
| Earnings Per Share (EPS) | -$6.89 |
Full Income StatementBalance Sheet
The company has $3.28 million in cash and $328,849 in debt, giving a net cash position of $2.96 million or $2.05 per share.
| Cash & Cash Equivalents | 3.28M |
| Total Debt | 328,849 |
| Net Cash | 2.96M |
| Net Cash Per Share | $2.05 |
| Equity (Book Value) | 2.92M |
| Book Value Per Share | 2.03 |
| Working Capital | 2.89M |
Full Balance SheetCash Flow
| Operating Cash Flow | -5.29M |
| Capital Expenditures | n/a |
| Free Cash Flow | -5.29M |
| FCF Per Share | -$3.67 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |